Objective To examine the power of dual mTORc1/c2 inhibitors together with lapatinib to operate within a synergistic way to inhibit cell proliferation and anchorage-independent development in bladder tumor cell lines. (38% vs. 4%) Em:AB023051.5 and reduced appearance of pAkt S473 (7.5% vs. 29%) and pAkt T308 (50% vs. 84%) in accordance with regular tissue. Significant… Continue reading Objective To examine the power of dual mTORc1/c2 inhibitors together with